nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP2D6—Lomustine—brain cancer	0.131	0.253	CbGbCtD
Temsirolimus—CYP2D6—Hydroxyurea—brain cancer	0.0996	0.192	CbGbCtD
Temsirolimus—CYP3A4—Temozolomide—brain cancer	0.0983	0.19	CbGbCtD
Temsirolimus—CYP3A4—Lomustine—brain cancer	0.0835	0.161	CbGbCtD
Temsirolimus—CYP3A5—Etoposide—brain cancer	0.0518	0.0999	CbGbCtD
Temsirolimus—ABCB1—Etoposide—brain cancer	0.0337	0.065	CbGbCtD
Temsirolimus—CYP3A4—Etoposide—brain cancer	0.0202	0.0389	CbGbCtD
Temsirolimus—MTOR—blood vessel—brain cancer	0.00401	0.0874	CbGeAlD
Temsirolimus—MTOR—hindbrain—brain cancer	0.00382	0.0834	CbGeAlD
Temsirolimus—MTOR—brainstem—brain cancer	0.00219	0.0478	CbGeAlD
Temsirolimus—MTOR—telencephalon—brain cancer	0.00194	0.0424	CbGeAlD
Temsirolimus—FKBP1A—telencephalon—brain cancer	0.00175	0.0381	CbGeAlD
Temsirolimus—MTOR—gonad—brain cancer	0.00162	0.0354	CbGeAlD
Temsirolimus—MTOR—pituitary gland—brain cancer	0.00158	0.0345	CbGeAlD
Temsirolimus—FKBP1A—gonad—brain cancer	0.00146	0.0318	CbGeAlD
Temsirolimus—FKBP1A—pituitary gland—brain cancer	0.00142	0.0311	CbGeAlD
Temsirolimus—FKBP1A—medulla oblongata—brain cancer	0.00137	0.03	CbGeAlD
Temsirolimus—CYP3A7—endocrine gland—brain cancer	0.00136	0.0298	CbGeAlD
Temsirolimus—MTOR—spinal cord—brain cancer	0.00136	0.0297	CbGeAlD
Temsirolimus—FKBP1A—midbrain—brain cancer	0.00126	0.0274	CbGeAlD
Temsirolimus—MTOR—endocrine gland—brain cancer	0.00123	0.0268	CbGeAlD
Temsirolimus—FKBP1A—spinal cord—brain cancer	0.00122	0.0267	CbGeAlD
Temsirolimus—MTOR—head—brain cancer	0.00121	0.0264	CbGeAlD
Temsirolimus—CYP2D6—hindbrain—brain cancer	0.00111	0.0241	CbGeAlD
Temsirolimus—MTOR—central nervous system—brain cancer	0.0011	0.0241	CbGeAlD
Temsirolimus—FKBP1A—endocrine gland—brain cancer	0.0011	0.0241	CbGeAlD
Temsirolimus—FKBP1A—head—brain cancer	0.00109	0.0238	CbGeAlD
Temsirolimus—MTOR—cerebellum—brain cancer	0.00108	0.0236	CbGeAlD
Temsirolimus—FKBP1A—central nervous system—brain cancer	0.000994	0.0217	CbGeAlD
Temsirolimus—FKBP1A—cerebellum—brain cancer	0.000971	0.0212	CbGeAlD
Temsirolimus—MTOR—brain—brain cancer	0.000877	0.0191	CbGeAlD
Temsirolimus—Face oedema—Carmustine—brain cancer	0.000845	0.00297	CcSEcCtD
Temsirolimus—Mouth ulceration—Etoposide—brain cancer	0.000843	0.00296	CcSEcCtD
Temsirolimus—Infestation NOS—Hydroxyurea—brain cancer	0.000835	0.00293	CcSEcCtD
Temsirolimus—Infestation—Hydroxyurea—brain cancer	0.000835	0.00293	CcSEcCtD
Temsirolimus—ABCB1—blood vessel—brain cancer	0.000834	0.0182	CbGeAlD
Temsirolimus—Face oedema—Temozolomide—brain cancer	0.000817	0.00287	CcSEcCtD
Temsirolimus—Stomatitis—Hydroxyurea—brain cancer	0.000814	0.00286	CcSEcCtD
Temsirolimus—Sepsis—Etoposide—brain cancer	0.000809	0.00284	CcSEcCtD
Temsirolimus—Hypokalaemia—Carmustine—brain cancer	0.000797	0.0028	CcSEcCtD
Temsirolimus—FKBP1A—brain—brain cancer	0.000789	0.0172	CbGeAlD
Temsirolimus—Dehydration—Temozolomide—brain cancer	0.000787	0.00276	CcSEcCtD
Temsirolimus—Anaemia—Procarbazine—brain cancer	0.000779	0.00274	CcSEcCtD
Temsirolimus—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000778	0.00274	CcSEcCtD
Temsirolimus—Dry skin—Temozolomide—brain cancer	0.000776	0.00273	CcSEcCtD
Temsirolimus—Hypokalaemia—Temozolomide—brain cancer	0.00077	0.00271	CcSEcCtD
Temsirolimus—Swelling—Etoposide—brain cancer	0.000768	0.0027	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000762	0.00268	CcSEcCtD
Temsirolimus—Dysphagia—Carmustine—brain cancer	0.000757	0.00266	CcSEcCtD
Temsirolimus—Leukopenia—Procarbazine—brain cancer	0.000754	0.00265	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000746	0.00262	CcSEcCtD
Temsirolimus—Abdominal distension—Temozolomide—brain cancer	0.000736	0.00259	CcSEcCtD
Temsirolimus—Cough—Procarbazine—brain cancer	0.000736	0.00258	CcSEcCtD
Temsirolimus—Dysphagia—Temozolomide—brain cancer	0.000731	0.00257	CcSEcCtD
Temsirolimus—Convulsion—Procarbazine—brain cancer	0.00073	0.00257	CcSEcCtD
Temsirolimus—Hypertension—Procarbazine—brain cancer	0.000728	0.00256	CcSEcCtD
Temsirolimus—Arthralgia—Procarbazine—brain cancer	0.000718	0.00252	CcSEcCtD
Temsirolimus—Myalgia—Procarbazine—brain cancer	0.000718	0.00252	CcSEcCtD
Temsirolimus—Anxiety—Procarbazine—brain cancer	0.000715	0.00251	CcSEcCtD
Temsirolimus—Neutropenia—Carmustine—brain cancer	0.000708	0.00249	CcSEcCtD
Temsirolimus—Bronchitis—Temozolomide—brain cancer	0.000703	0.00247	CcSEcCtD
Temsirolimus—Vomiting—Lomustine—brain cancer	0.000689	0.00242	CcSEcCtD
Temsirolimus—Oedema—Procarbazine—brain cancer	0.000688	0.00242	CcSEcCtD
Temsirolimus—Dysuria—Temozolomide—brain cancer	0.000684	0.0024	CcSEcCtD
Temsirolimus—Neutropenia—Temozolomide—brain cancer	0.000684	0.0024	CcSEcCtD
Temsirolimus—Infection—Procarbazine—brain cancer	0.000683	0.0024	CcSEcCtD
Temsirolimus—Hyperglycaemia—Carmustine—brain cancer	0.000683	0.0024	CcSEcCtD
Temsirolimus—Angiopathy—Hydroxyurea—brain cancer	0.00068	0.00239	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Temozolomide—brain cancer	0.00068	0.00239	CcSEcCtD
Temsirolimus—Pneumonia—Carmustine—brain cancer	0.000679	0.00238	CcSEcCtD
Temsirolimus—Pollakiuria—Temozolomide—brain cancer	0.000676	0.00237	CcSEcCtD
Temsirolimus—Thrombocytopenia—Procarbazine—brain cancer	0.000674	0.00237	CcSEcCtD
Temsirolimus—Depression—Carmustine—brain cancer	0.000673	0.00236	CcSEcCtD
Temsirolimus—Chills—Hydroxyurea—brain cancer	0.000672	0.00236	CcSEcCtD
Temsirolimus—Renal failure—Carmustine—brain cancer	0.000663	0.00233	CcSEcCtD
Temsirolimus—Weight decreased—Temozolomide—brain cancer	0.000662	0.00232	CcSEcCtD
Temsirolimus—Hyperglycaemia—Temozolomide—brain cancer	0.00066	0.00232	CcSEcCtD
Temsirolimus—Stomatitis—Carmustine—brain cancer	0.000658	0.00231	CcSEcCtD
Temsirolimus—Urinary tract infection—Carmustine—brain cancer	0.000656	0.0023	CcSEcCtD
Temsirolimus—Pneumonia—Temozolomide—brain cancer	0.000656	0.0023	CcSEcCtD
Temsirolimus—Anorexia—Procarbazine—brain cancer	0.000656	0.0023	CcSEcCtD
Temsirolimus—Erythema—Hydroxyurea—brain cancer	0.000652	0.00229	CcSEcCtD
Temsirolimus—Infestation NOS—Temozolomide—brain cancer	0.000652	0.00229	CcSEcCtD
Temsirolimus—Infestation—Temozolomide—brain cancer	0.000652	0.00229	CcSEcCtD
Temsirolimus—Depression—Temozolomide—brain cancer	0.00065	0.00228	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000647	0.00227	CcSEcCtD
Temsirolimus—Nausea—Lomustine—brain cancer	0.000644	0.00226	CcSEcCtD
Temsirolimus—Stomatitis—Temozolomide—brain cancer	0.000636	0.00223	CcSEcCtD
Temsirolimus—Urinary tract infection—Temozolomide—brain cancer	0.000634	0.00223	CcSEcCtD
Temsirolimus—CYP2D6—brainstem—brain cancer	0.000633	0.0138	CbGeAlD
Temsirolimus—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000627	0.0022	CcSEcCtD
Temsirolimus—Insomnia—Procarbazine—brain cancer	0.000622	0.00219	CcSEcCtD
Temsirolimus—Sinusitis—Temozolomide—brain cancer	0.000612	0.00215	CcSEcCtD
Temsirolimus—Somnolence—Procarbazine—brain cancer	0.000612	0.00215	CcSEcCtD
Temsirolimus—Anaemia—Hydroxyurea—brain cancer	0.000603	0.00212	CcSEcCtD
Temsirolimus—Decreased appetite—Procarbazine—brain cancer	0.000598	0.0021	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Etoposide—brain cancer	0.000597	0.0021	CcSEcCtD
Temsirolimus—Oedema peripheral—Carmustine—brain cancer	0.000597	0.0021	CcSEcCtD
Temsirolimus—Connective tissue disorder—Carmustine—brain cancer	0.000595	0.00209	CcSEcCtD
Temsirolimus—Fatigue—Procarbazine—brain cancer	0.000593	0.00208	CcSEcCtD
Temsirolimus—Pain—Procarbazine—brain cancer	0.000588	0.00207	CcSEcCtD
Temsirolimus—Constipation—Procarbazine—brain cancer	0.000588	0.00207	CcSEcCtD
Temsirolimus—Dysphagia—Etoposide—brain cancer	0.000585	0.00206	CcSEcCtD
Temsirolimus—Leukopenia—Hydroxyurea—brain cancer	0.000584	0.00205	CcSEcCtD
Temsirolimus—Pharyngitis—Temozolomide—brain cancer	0.000581	0.00204	CcSEcCtD
Temsirolimus—Urinary tract disorder—Temozolomide—brain cancer	0.000578	0.00203	CcSEcCtD
Temsirolimus—Oedema peripheral—Temozolomide—brain cancer	0.000577	0.00203	CcSEcCtD
Temsirolimus—Connective tissue disorder—Temozolomide—brain cancer	0.000575	0.00202	CcSEcCtD
Temsirolimus—Urethral disorder—Temozolomide—brain cancer	0.000574	0.00202	CcSEcCtD
Temsirolimus—Eye disorder—Carmustine—brain cancer	0.000566	0.00199	CcSEcCtD
Temsirolimus—Convulsion—Hydroxyurea—brain cancer	0.000565	0.00199	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Procarbazine—brain cancer	0.000563	0.00198	CcSEcCtD
Temsirolimus—CYP2D6—telencephalon—brain cancer	0.000562	0.0123	CbGeAlD
Temsirolimus—Erythema multiforme—Temozolomide—brain cancer	0.000554	0.00194	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000552	0.00194	CcSEcCtD
Temsirolimus—Neutropenia—Etoposide—brain cancer	0.000547	0.00192	CcSEcCtD
Temsirolimus—Eye disorder—Temozolomide—brain cancer	0.000547	0.00192	CcSEcCtD
Temsirolimus—Body temperature increased—Procarbazine—brain cancer	0.000544	0.00191	CcSEcCtD
Temsirolimus—Abdominal pain—Procarbazine—brain cancer	0.000544	0.00191	CcSEcCtD
Temsirolimus—Cardiac disorder—Temozolomide—brain cancer	0.000543	0.00191	CcSEcCtD
Temsirolimus—Oedema—Hydroxyurea—brain cancer	0.000532	0.00187	CcSEcCtD
Temsirolimus—Angiopathy—Temozolomide—brain cancer	0.000531	0.00187	CcSEcCtD
Temsirolimus—Mental disorder—Carmustine—brain cancer	0.000531	0.00186	CcSEcCtD
Temsirolimus—Infection—Hydroxyurea—brain cancer	0.000529	0.00186	CcSEcCtD
Temsirolimus—Immune system disorder—Temozolomide—brain cancer	0.000529	0.00186	CcSEcCtD
Temsirolimus—Mediastinal disorder—Temozolomide—brain cancer	0.000528	0.00185	CcSEcCtD
Temsirolimus—Malnutrition—Carmustine—brain cancer	0.000527	0.00185	CcSEcCtD
Temsirolimus—Erythema—Carmustine—brain cancer	0.000527	0.00185	CcSEcCtD
Temsirolimus—Chills—Temozolomide—brain cancer	0.000525	0.00185	CcSEcCtD
Temsirolimus—Pneumonia—Etoposide—brain cancer	0.000525	0.00184	CcSEcCtD
Temsirolimus—Nervous system disorder—Hydroxyurea—brain cancer	0.000522	0.00183	CcSEcCtD
Temsirolimus—Infestation NOS—Etoposide—brain cancer	0.000522	0.00183	CcSEcCtD
Temsirolimus—Infestation—Etoposide—brain cancer	0.000522	0.00183	CcSEcCtD
Temsirolimus—Thrombocytopenia—Hydroxyurea—brain cancer	0.000521	0.00183	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000517	0.00182	CcSEcCtD
Temsirolimus—Skin disorder—Hydroxyurea—brain cancer	0.000517	0.00182	CcSEcCtD
Temsirolimus—Renal failure—Etoposide—brain cancer	0.000513	0.0018	CcSEcCtD
Temsirolimus—Mental disorder—Temozolomide—brain cancer	0.000513	0.0018	CcSEcCtD
Temsirolimus—Back pain—Carmustine—brain cancer	0.00051	0.00179	CcSEcCtD
Temsirolimus—Malnutrition—Temozolomide—brain cancer	0.00051	0.00179	CcSEcCtD
Temsirolimus—Erythema—Temozolomide—brain cancer	0.00051	0.00179	CcSEcCtD
Temsirolimus—Stomatitis—Etoposide—brain cancer	0.000509	0.00179	CcSEcCtD
Temsirolimus—Anorexia—Hydroxyurea—brain cancer	0.000507	0.00178	CcSEcCtD
Temsirolimus—Hypersensitivity—Procarbazine—brain cancer	0.000507	0.00178	CcSEcCtD
Temsirolimus—Dysgeusia—Temozolomide—brain cancer	0.000499	0.00175	CcSEcCtD
Temsirolimus—Asthenia—Procarbazine—brain cancer	0.000494	0.00173	CcSEcCtD
Temsirolimus—Back pain—Temozolomide—brain cancer	0.000493	0.00173	CcSEcCtD
Temsirolimus—Anaemia—Carmustine—brain cancer	0.000487	0.00171	CcSEcCtD
Temsirolimus—Pruritus—Procarbazine—brain cancer	0.000487	0.00171	CcSEcCtD
Temsirolimus—CYP3A5—endocrine gland—brain cancer	0.00048	0.0105	CbGeAlD
Temsirolimus—Dyspnoea—Hydroxyurea—brain cancer	0.000475	0.00167	CcSEcCtD
Temsirolimus—Somnolence—Hydroxyurea—brain cancer	0.000473	0.00166	CcSEcCtD
Temsirolimus—Leukopenia—Carmustine—brain cancer	0.000472	0.00166	CcSEcCtD
Temsirolimus—Anaemia—Temozolomide—brain cancer	0.000471	0.00165	CcSEcCtD
Temsirolimus—Diarrhoea—Procarbazine—brain cancer	0.000471	0.00165	CcSEcCtD
Temsirolimus—Angioedema—Temozolomide—brain cancer	0.000466	0.00164	CcSEcCtD
Temsirolimus—Decreased appetite—Hydroxyurea—brain cancer	0.000463	0.00163	CcSEcCtD
Temsirolimus—Urinary tract disorder—Etoposide—brain cancer	0.000463	0.00163	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00046	0.00161	CcSEcCtD
Temsirolimus—Urethral disorder—Etoposide—brain cancer	0.000459	0.00161	CcSEcCtD
Temsirolimus—Fatigue—Hydroxyurea—brain cancer	0.000459	0.00161	CcSEcCtD
Temsirolimus—Convulsion—Carmustine—brain cancer	0.000457	0.00161	CcSEcCtD
Temsirolimus—Leukopenia—Temozolomide—brain cancer	0.000456	0.0016	CcSEcCtD
Temsirolimus—Hypertension—Carmustine—brain cancer	0.000455	0.0016	CcSEcCtD
Temsirolimus—Constipation—Hydroxyurea—brain cancer	0.000455	0.0016	CcSEcCtD
Temsirolimus—Pain—Hydroxyurea—brain cancer	0.000455	0.0016	CcSEcCtD
Temsirolimus—Dizziness—Procarbazine—brain cancer	0.000455	0.0016	CcSEcCtD
Temsirolimus—Myalgia—Carmustine—brain cancer	0.000449	0.00158	CcSEcCtD
Temsirolimus—Chest pain—Carmustine—brain cancer	0.000449	0.00158	CcSEcCtD
Temsirolimus—Anxiety—Carmustine—brain cancer	0.000447	0.00157	CcSEcCtD
Temsirolimus—Cough—Temozolomide—brain cancer	0.000445	0.00156	CcSEcCtD
Temsirolimus—Erythema multiforme—Etoposide—brain cancer	0.000443	0.00156	CcSEcCtD
Temsirolimus—Convulsion—Temozolomide—brain cancer	0.000442	0.00155	CcSEcCtD
Temsirolimus—Hypertension—Temozolomide—brain cancer	0.00044	0.00155	CcSEcCtD
Temsirolimus—Eye disorder—Etoposide—brain cancer	0.000438	0.00154	CcSEcCtD
Temsirolimus—Vomiting—Procarbazine—brain cancer	0.000437	0.00154	CcSEcCtD
Temsirolimus—Cardiac disorder—Etoposide—brain cancer	0.000435	0.00153	CcSEcCtD
Temsirolimus—Myalgia—Temozolomide—brain cancer	0.000434	0.00152	CcSEcCtD
Temsirolimus—Arthralgia—Temozolomide—brain cancer	0.000434	0.00152	CcSEcCtD
Temsirolimus—Rash—Procarbazine—brain cancer	0.000434	0.00152	CcSEcCtD
Temsirolimus—Dermatitis—Procarbazine—brain cancer	0.000433	0.00152	CcSEcCtD
Temsirolimus—Anxiety—Temozolomide—brain cancer	0.000432	0.00152	CcSEcCtD
Temsirolimus—Headache—Procarbazine—brain cancer	0.000431	0.00151	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000431	0.00151	CcSEcCtD
Temsirolimus—Oedema—Carmustine—brain cancer	0.00043	0.00151	CcSEcCtD
Temsirolimus—Infection—Carmustine—brain cancer	0.000428	0.0015	CcSEcCtD
Temsirolimus—Angiopathy—Etoposide—brain cancer	0.000425	0.00149	CcSEcCtD
Temsirolimus—Immune system disorder—Etoposide—brain cancer	0.000423	0.00149	CcSEcCtD
Temsirolimus—Mediastinal disorder—Etoposide—brain cancer	0.000422	0.00148	CcSEcCtD
Temsirolimus—Thrombocytopenia—Carmustine—brain cancer	0.000421	0.00148	CcSEcCtD
Temsirolimus—Body temperature increased—Hydroxyurea—brain cancer	0.000421	0.00148	CcSEcCtD
Temsirolimus—Chills—Etoposide—brain cancer	0.00042	0.00148	CcSEcCtD
Temsirolimus—Oedema—Temozolomide—brain cancer	0.000416	0.00146	CcSEcCtD
Temsirolimus—Anaphylactic shock—Temozolomide—brain cancer	0.000416	0.00146	CcSEcCtD
Temsirolimus—Infection—Temozolomide—brain cancer	0.000413	0.00145	CcSEcCtD
Temsirolimus—Anorexia—Carmustine—brain cancer	0.00041	0.00144	CcSEcCtD
Temsirolimus—Nausea—Procarbazine—brain cancer	0.000409	0.00144	CcSEcCtD
Temsirolimus—Nervous system disorder—Temozolomide—brain cancer	0.000408	0.00143	CcSEcCtD
Temsirolimus—Thrombocytopenia—Temozolomide—brain cancer	0.000407	0.00143	CcSEcCtD
Temsirolimus—ABCB1—telencephalon—brain cancer	0.000404	0.00882	CbGeAlD
Temsirolimus—Skin disorder—Temozolomide—brain cancer	0.000404	0.00142	CcSEcCtD
Temsirolimus—Dysgeusia—Etoposide—brain cancer	0.000399	0.0014	CcSEcCtD
Temsirolimus—Anorexia—Temozolomide—brain cancer	0.000396	0.00139	CcSEcCtD
Temsirolimus—Back pain—Etoposide—brain cancer	0.000394	0.00139	CcSEcCtD
Temsirolimus—Hypersensitivity—Hydroxyurea—brain cancer	0.000392	0.00138	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Carmustine—brain cancer	0.000392	0.00138	CcSEcCtD
Temsirolimus—Insomnia—Carmustine—brain cancer	0.000389	0.00137	CcSEcCtD
Temsirolimus—Dyspnoea—Carmustine—brain cancer	0.000384	0.00135	CcSEcCtD
Temsirolimus—Somnolence—Carmustine—brain cancer	0.000383	0.00134	CcSEcCtD
Temsirolimus—Asthenia—Hydroxyurea—brain cancer	0.000382	0.00134	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000379	0.00133	CcSEcCtD
Temsirolimus—Anaemia—Etoposide—brain cancer	0.000377	0.00132	CcSEcCtD
Temsirolimus—Insomnia—Temozolomide—brain cancer	0.000376	0.00132	CcSEcCtD
Temsirolimus—Decreased appetite—Carmustine—brain cancer	0.000374	0.00131	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Carmustine—brain cancer	0.000372	0.00131	CcSEcCtD
Temsirolimus—Dyspnoea—Temozolomide—brain cancer	0.000371	0.0013	CcSEcCtD
Temsirolimus—Somnolence—Temozolomide—brain cancer	0.00037	0.0013	CcSEcCtD
Temsirolimus—Constipation—Carmustine—brain cancer	0.000368	0.00129	CcSEcCtD
Temsirolimus—Pain—Carmustine—brain cancer	0.000368	0.00129	CcSEcCtD
Temsirolimus—Leukopenia—Etoposide—brain cancer	0.000365	0.00128	CcSEcCtD
Temsirolimus—Diarrhoea—Hydroxyurea—brain cancer	0.000364	0.00128	CcSEcCtD
Temsirolimus—Decreased appetite—Temozolomide—brain cancer	0.000362	0.00127	CcSEcCtD
Temsirolimus—CYP3A4—endocrine gland—brain cancer	0.00036	0.00786	CbGeAlD
Temsirolimus—Gastrointestinal disorder—Temozolomide—brain cancer	0.000359	0.00126	CcSEcCtD
Temsirolimus—Fatigue—Temozolomide—brain cancer	0.000359	0.00126	CcSEcCtD
Temsirolimus—Cough—Etoposide—brain cancer	0.000356	0.00125	CcSEcCtD
Temsirolimus—Pain—Temozolomide—brain cancer	0.000356	0.00125	CcSEcCtD
Temsirolimus—Constipation—Temozolomide—brain cancer	0.000356	0.00125	CcSEcCtD
Temsirolimus—CYP2D6—endocrine gland—brain cancer	0.000355	0.00774	CbGeAlD
Temsirolimus—Convulsion—Etoposide—brain cancer	0.000353	0.00124	CcSEcCtD
Temsirolimus—Hypertension—Etoposide—brain cancer	0.000352	0.00124	CcSEcCtD
Temsirolimus—Dizziness—Hydroxyurea—brain cancer	0.000352	0.00124	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Carmustine—brain cancer	0.000352	0.00124	CcSEcCtD
Temsirolimus—CYP2D6—head—brain cancer	0.00035	0.00764	CbGeAlD
Temsirolimus—Chest pain—Etoposide—brain cancer	0.000347	0.00122	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000345	0.00121	CcSEcCtD
Temsirolimus—Body temperature increased—Carmustine—brain cancer	0.00034	0.0012	CcSEcCtD
Temsirolimus—Abdominal pain—Carmustine—brain cancer	0.00034	0.0012	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Temozolomide—brain cancer	0.00034	0.00119	CcSEcCtD
Temsirolimus—Vomiting—Hydroxyurea—brain cancer	0.000338	0.00119	CcSEcCtD
Temsirolimus—ABCB1—gonad—brain cancer	0.000338	0.00736	CbGeAlD
Temsirolimus—Rash—Hydroxyurea—brain cancer	0.000336	0.00118	CcSEcCtD
Temsirolimus—Dermatitis—Hydroxyurea—brain cancer	0.000335	0.00118	CcSEcCtD
Temsirolimus—Headache—Hydroxyurea—brain cancer	0.000334	0.00117	CcSEcCtD
Temsirolimus—Anaphylactic shock—Etoposide—brain cancer	0.000333	0.00117	CcSEcCtD
Temsirolimus—Infection—Etoposide—brain cancer	0.000331	0.00116	CcSEcCtD
Temsirolimus—ABCB1—pituitary gland—brain cancer	0.000329	0.00719	CbGeAlD
Temsirolimus—Abdominal pain—Temozolomide—brain cancer	0.000329	0.00116	CcSEcCtD
Temsirolimus—Body temperature increased—Temozolomide—brain cancer	0.000329	0.00116	CcSEcCtD
Temsirolimus—Thrombocytopenia—Etoposide—brain cancer	0.000326	0.00114	CcSEcCtD
Temsirolimus—CYP3A4—central nervous system—brain cancer	0.000325	0.00709	CbGeAlD
Temsirolimus—Skin disorder—Etoposide—brain cancer	0.000323	0.00114	CcSEcCtD
Temsirolimus—CYP2D6—central nervous system—brain cancer	0.00032	0.00697	CbGeAlD
Temsirolimus—ABCB1—medulla oblongata—brain cancer	0.000318	0.00693	CbGeAlD
Temsirolimus—Anorexia—Etoposide—brain cancer	0.000317	0.00111	CcSEcCtD
Temsirolimus—Hypersensitivity—Carmustine—brain cancer	0.000317	0.00111	CcSEcCtD
Temsirolimus—Nausea—Hydroxyurea—brain cancer	0.000316	0.00111	CcSEcCtD
Temsirolimus—CYP2D6—cerebellum—brain cancer	0.000312	0.00682	CbGeAlD
Temsirolimus—Asthenia—Carmustine—brain cancer	0.000309	0.00108	CcSEcCtD
Temsirolimus—Hypersensitivity—Temozolomide—brain cancer	0.000306	0.00108	CcSEcCtD
Temsirolimus—Asthenia—Temozolomide—brain cancer	0.000298	0.00105	CcSEcCtD
Temsirolimus—Dyspnoea—Etoposide—brain cancer	0.000297	0.00104	CcSEcCtD
Temsirolimus—Somnolence—Etoposide—brain cancer	0.000296	0.00104	CcSEcCtD
Temsirolimus—Diarrhoea—Carmustine—brain cancer	0.000294	0.00103	CcSEcCtD
Temsirolimus—Pruritus—Temozolomide—brain cancer	0.000294	0.00103	CcSEcCtD
Temsirolimus—ABCB1—midbrain—brain cancer	0.00029	0.00634	CbGeAlD
Temsirolimus—Decreased appetite—Etoposide—brain cancer	0.000289	0.00102	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Etoposide—brain cancer	0.000287	0.00101	CcSEcCtD
Temsirolimus—Fatigue—Etoposide—brain cancer	0.000287	0.00101	CcSEcCtD
Temsirolimus—Dizziness—Carmustine—brain cancer	0.000285	0.001	CcSEcCtD
Temsirolimus—Constipation—Etoposide—brain cancer	0.000285	0.001	CcSEcCtD
Temsirolimus—Pain—Etoposide—brain cancer	0.000285	0.001	CcSEcCtD
Temsirolimus—Diarrhoea—Temozolomide—brain cancer	0.000285	0.001	CcSEcCtD
Temsirolimus—ABCB1—spinal cord—brain cancer	0.000283	0.00618	CbGeAlD
Temsirolimus—Dizziness—Temozolomide—brain cancer	0.000275	0.000966	CcSEcCtD
Temsirolimus—Vomiting—Carmustine—brain cancer	0.000274	0.000961	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Etoposide—brain cancer	0.000272	0.000956	CcSEcCtD
Temsirolimus—Rash—Carmustine—brain cancer	0.000271	0.000953	CcSEcCtD
Temsirolimus—Dermatitis—Carmustine—brain cancer	0.000271	0.000952	CcSEcCtD
Temsirolimus—Headache—Carmustine—brain cancer	0.00027	0.000947	CcSEcCtD
Temsirolimus—Vomiting—Temozolomide—brain cancer	0.000264	0.000929	CcSEcCtD
Temsirolimus—Abdominal pain—Etoposide—brain cancer	0.000263	0.000924	CcSEcCtD
Temsirolimus—Body temperature increased—Etoposide—brain cancer	0.000263	0.000924	CcSEcCtD
Temsirolimus—Rash—Temozolomide—brain cancer	0.000262	0.000921	CcSEcCtD
Temsirolimus—Dermatitis—Temozolomide—brain cancer	0.000262	0.00092	CcSEcCtD
Temsirolimus—Headache—Temozolomide—brain cancer	0.000261	0.000915	CcSEcCtD
Temsirolimus—Nausea—Carmustine—brain cancer	0.000256	0.000898	CcSEcCtD
Temsirolimus—ABCB1—endocrine gland—brain cancer	0.000255	0.00557	CbGeAlD
Temsirolimus—CYP2D6—brain—brain cancer	0.000254	0.00554	CbGeAlD
Temsirolimus—ABCB1—head—brain cancer	0.000252	0.0055	CbGeAlD
Temsirolimus—Nausea—Temozolomide—brain cancer	0.000247	0.000868	CcSEcCtD
Temsirolimus—Hypersensitivity—Etoposide—brain cancer	0.000245	0.000861	CcSEcCtD
Temsirolimus—Asthenia—Etoposide—brain cancer	0.000239	0.000839	CcSEcCtD
Temsirolimus—Pruritus—Etoposide—brain cancer	0.000235	0.000827	CcSEcCtD
Temsirolimus—ABCB1—central nervous system—brain cancer	0.00023	0.00502	CbGeAlD
Temsirolimus—Diarrhoea—Etoposide—brain cancer	0.000228	0.0008	CcSEcCtD
Temsirolimus—ABCB1—cerebellum—brain cancer	0.000225	0.0049	CbGeAlD
Temsirolimus—Dizziness—Etoposide—brain cancer	0.00022	0.000773	CcSEcCtD
Temsirolimus—Vomiting—Etoposide—brain cancer	0.000212	0.000743	CcSEcCtD
Temsirolimus—Rash—Etoposide—brain cancer	0.00021	0.000737	CcSEcCtD
Temsirolimus—Dermatitis—Etoposide—brain cancer	0.00021	0.000737	CcSEcCtD
Temsirolimus—Headache—Etoposide—brain cancer	0.000208	0.000732	CcSEcCtD
Temsirolimus—Nausea—Etoposide—brain cancer	0.000198	0.000695	CcSEcCtD
Temsirolimus—ABCB1—brain—brain cancer	0.000182	0.00398	CbGeAlD
Temsirolimus—MTOR—Cellular responses to stress—CCNE1—brain cancer	0.000176	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—TP53—brain cancer	0.000176	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IRS2—brain cancer	0.000175	0.00116	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000175	0.00116	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—SOD2—brain cancer	0.000172	0.00114	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HEY1—brain cancer	0.00017	0.00112	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—OR4C12—brain cancer	0.000168	0.00111	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—OR14C36—brain cancer	0.000168	0.00111	CbGpPWpGaD
Temsirolimus—MTOR—AMPK Signaling—TP53—brain cancer	0.000168	0.00111	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—CTNNB1—brain cancer	0.000168	0.00111	CbGpPWpGaD
Temsirolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—EGFR—brain cancer	0.000168	0.00111	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—DLL1—brain cancer	0.000166	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—ERBB2—brain cancer	0.000163	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—RELA—brain cancer	0.000161	0.00107	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000161	0.00107	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000157	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—STAT3—brain cancer	0.000157	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—VEGFA—brain cancer	0.000156	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—ERBB2—brain cancer	0.000156	0.00103	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000154	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—PDGFRA—brain cancer	0.000154	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—ERBB2—brain cancer	0.000153	0.00101	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ABR—brain cancer	0.000151	0.001	CbGpPWpGaD
Temsirolimus—MTOR—PI-3K cascade—EGFR—brain cancer	0.000151	0.000999	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HES5—brain cancer	0.00015	0.000991	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—VEGFA—brain cancer	0.000148	0.000977	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—EGFR—brain cancer	0.000147	0.000976	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—ERBB2—brain cancer	0.000146	0.000969	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000146	0.000969	CbGpPWpGaD
Temsirolimus—MTOR—GAB1 signalosome—EGFR—brain cancer	0.000146	0.000968	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GLI2—brain cancer	0.000146	0.000965	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—ERBB2—brain cancer	0.000146	0.000965	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—ERBB2—brain cancer	0.000146	0.000965	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—ERBB2—brain cancer	0.000145	0.00096	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—ERBB2—brain cancer	0.000144	0.000955	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—RELA—brain cancer	0.000143	0.000947	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—EGFR—brain cancer	0.000143	0.000946	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—brain cancer	0.000143	0.000946	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DTX2—brain cancer	0.000143	0.000945	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—brain cancer	0.000142	0.000941	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—ENO2—brain cancer	0.000142	0.000937	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SHH—brain cancer	0.000142	0.000937	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—CTNNB1—brain cancer	0.00014	0.000927	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GLI1—brain cancer	0.000137	0.000908	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—RELA—brain cancer	0.000137	0.000904	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000136	0.000901	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—ERBB2—brain cancer	0.000136	0.000899	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—ERBB2—brain cancer	0.000136	0.000899	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—ERBB2—brain cancer	0.000136	0.000899	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDK4—brain cancer	0.000135	0.000893	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000135	0.000893	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IRS2—brain cancer	0.000135	0.000893	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—SKP2—brain cancer	0.000135	0.000892	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—ERBB2—brain cancer	0.000135	0.000891	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—ERBB2—brain cancer	0.000133	0.000883	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—ERBB2—brain cancer	0.000133	0.000879	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000132	0.000875	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SUFU—brain cancer	0.00013	0.000861	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000128	0.000847	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—RELA—brain cancer	0.000126	0.000837	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—ERBB2—brain cancer	0.000126	0.000832	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GFAP—brain cancer	0.000125	0.00083	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—STAT3—brain cancer	0.000124	0.000822	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000124	0.000818	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—STAT3—brain cancer	0.000122	0.000808	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	0.00012	0.000796	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—brain cancer	0.00012	0.000794	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HEY1—brain cancer	0.000119	0.000787	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000119	0.000786	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—DLL1—brain cancer	0.000117	0.000772	CbGpPWpGaD
Temsirolimus—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000116	0.000766	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—EGFR—brain cancer	0.000113	0.000747	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—STAT3—brain cancer	0.000112	0.000739	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—STAT3—brain cancer	0.000111	0.000736	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000109	0.000723	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTCH2—brain cancer	0.000108	0.000716	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—EGFR—brain cancer	0.000108	0.000715	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—VAV1—brain cancer	0.000107	0.000708	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000107	0.000707	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—EGFR—brain cancer	0.000106	0.000704	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HES5—brain cancer	0.000105	0.000694	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—STAT3—brain cancer	0.000104	0.000685	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN2A—brain cancer	0.000103	0.000682	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—VAV1—brain cancer	0.000103	0.00068	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—VAV1—brain cancer	0.000102	0.000677	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STRADA—brain cancer	0.000102	0.000674	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—EGFR—brain cancer	0.000101	0.000672	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000101	0.000671	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—STAT3—brain cancer	0.000101	0.00067	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—brain cancer	0.000101	0.000669	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—EGFR—brain cancer	0.000101	0.000669	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL2—brain cancer	0.000101	0.000668	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IDH1—brain cancer	0.000101	0.000667	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—EGFR—brain cancer	0.0001	0.000665	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—EGFR—brain cancer	0.0001	0.000662	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	9.95e-05	0.000658	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—RELA—brain cancer	9.92e-05	0.000657	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SHH—brain cancer	9.91e-05	0.000656	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	9.91e-05	0.000656	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—brain cancer	9.86e-05	0.000653	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	9.82e-05	0.00065	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TRPC6—brain cancer	9.56e-05	0.000633	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HEY1—brain cancer	9.55e-05	0.000632	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—EGFR—brain cancer	9.41e-05	0.000623	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—EGFR—brain cancer	9.41e-05	0.000623	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	9.41e-05	0.000623	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTCH1—brain cancer	9.4e-05	0.000622	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SMO—brain cancer	9.4e-05	0.000622	CbGpPWpGaD
Temsirolimus—MTOR—Disease—DLL1—brain cancer	9.36e-05	0.00062	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—EGFR—brain cancer	9.32e-05	0.000617	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—RELA—brain cancer	9.3e-05	0.000616	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—ERBB2—brain cancer	9.25e-05	0.000612	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—EGFR—brain cancer	9.24e-05	0.000612	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—EGFR—brain cancer	9.2e-05	0.000609	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	9.17e-05	0.000607	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	9.13e-05	0.000605	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP2C9—brain cancer	9.11e-05	0.000603	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—brain cancer	8.97e-05	0.000594	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HES1—brain cancer	8.8e-05	0.000582	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PDGFRA—brain cancer	8.76e-05	0.00058	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—EGFR—brain cancer	8.71e-05	0.000576	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.7e-05	0.000576	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—VEGFA—brain cancer	8.58e-05	0.000568	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ABR—brain cancer	8.49e-05	0.000562	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PDGFRA—brain cancer	8.41e-05	0.000557	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PDGFRA—brain cancer	8.38e-05	0.000554	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	8.33e-05	0.000552	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GLI2—brain cancer	8.2e-05	0.000543	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—SKP2—brain cancer	8.18e-05	0.000541	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SHH—brain cancer	7.96e-05	0.000527	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ENO2—brain cancer	7.96e-05	0.000527	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—BSG—brain cancer	7.74e-05	0.000513	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GLI1—brain cancer	7.71e-05	0.000511	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IRS2—brain cancer	7.69e-05	0.000509	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—VEGFA—brain cancer	7.59e-05	0.000503	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.52e-05	0.000498	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—STAT3—brain cancer	7.52e-05	0.000498	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOTCH2—brain cancer	7.51e-05	0.000497	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—IRS2—brain cancer	7.38e-05	0.000489	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IRS2—brain cancer	7.35e-05	0.000487	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SUFU—brain cancer	7.31e-05	0.000484	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VAV1—brain cancer	7.16e-05	0.000474	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	7.08e-05	0.000469	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GFAP—brain cancer	7.05e-05	0.000467	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—STAT3—brain cancer	7.05e-05	0.000467	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HEY1—brain cancer	6.69e-05	0.000443	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—IDH1—brain cancer	6.66e-05	0.000441	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP2C9—brain cancer	6.58e-05	0.000436	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DLL1—brain cancer	6.56e-05	0.000434	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—APC—brain cancer	6.49e-05	0.00043	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—EGFR—brain cancer	6.41e-05	0.000424	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—VAV1—brain cancer	6.23e-05	0.000412	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HES1—brain cancer	6.16e-05	0.000408	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.91e-05	0.000391	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PDGFRA—brain cancer	5.87e-05	0.000388	CbGpPWpGaD
Temsirolimus—MTOR—Disease—VAV1—brain cancer	5.75e-05	0.000381	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—brain cancer	5.74e-05	0.00038	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SPP1—brain cancer	5.69e-05	0.000377	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—BSG—brain cancer	5.6e-05	0.00037	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SHH—brain cancer	5.58e-05	0.000369	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.5e-05	0.000364	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TRPC6—brain cancer	5.38e-05	0.000356	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—RELA—brain cancer	5.31e-05	0.000351	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SMO—brain cancer	5.29e-05	0.00035	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTCH1—brain cancer	5.29e-05	0.00035	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—ERBB2—brain cancer	5.27e-05	0.000349	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ENO2—brain cancer	5.26e-05	0.000348	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IRS2—brain cancer	5.15e-05	0.000341	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PDGFRA—brain cancer	5.1e-05	0.000338	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—RELA—brain cancer	5.1e-05	0.000337	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ERBB2—brain cancer	5.06e-05	0.000335	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—ERBB2—brain cancer	5.04e-05	0.000334	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2C9—brain cancer	4.97e-05	0.000329	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HES1—brain cancer	4.95e-05	0.000328	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.86e-05	0.000322	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—IDH1—brain cancer	4.81e-05	0.000319	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.81e-05	0.000318	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PDGFRA—brain cancer	4.71e-05	0.000312	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2C9—brain cancer	4.68e-05	0.00031	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CTNNB1—brain cancer	4.61e-05	0.000305	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—APC—brain cancer	4.55e-05	0.000301	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CG—brain cancer	4.55e-05	0.000301	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IRS2—brain cancer	4.48e-05	0.000297	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CTNNB1—brain cancer	4.41e-05	0.000292	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.23e-05	0.00028	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOTCH2—brain cancer	4.23e-05	0.00028	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—BSG—brain cancer	4.22e-05	0.00028	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IRS2—brain cancer	4.14e-05	0.000274	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VAV1—brain cancer	4.03e-05	0.000267	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—BSG—brain cancer	3.98e-05	0.000263	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.9e-05	0.000258	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STAT3—brain cancer	3.85e-05	0.000255	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.81e-05	0.000252	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ENO2—brain cancer	3.8e-05	0.000252	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EGFR—brain cancer	3.66e-05	0.000242	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APC—brain cancer	3.65e-05	0.000242	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—IDH1—brain cancer	3.63e-05	0.00024	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MYC—brain cancer	3.57e-05	0.000237	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RELA—brain cancer	3.55e-05	0.000235	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ERBB2—brain cancer	3.53e-05	0.000234	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—EGFR—brain cancer	3.51e-05	0.000232	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EGFR—brain cancer	3.5e-05	0.000231	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HES1—brain cancer	3.46e-05	0.000229	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—IDH1—brain cancer	3.42e-05	0.000227	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PDGFRA—brain cancer	3.3e-05	0.000218	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SPP1—brain cancer	3.2e-05	0.000212	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—brain cancer	3.2e-05	0.000212	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.2e-05	0.000212	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCND1—brain cancer	3.12e-05	0.000207	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RELA—brain cancer	3.09e-05	0.000205	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CTNNB1—brain cancer	3.09e-05	0.000205	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ERBB2—brain cancer	3.07e-05	0.000203	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2C9—brain cancer	3.06e-05	0.000203	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IRS2—brain cancer	2.9e-05	0.000192	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ENO2—brain cancer	2.87e-05	0.00019	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ERBB2—brain cancer	2.84e-05	0.000188	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—brain cancer	2.78e-05	0.000184	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—brain cancer	2.72e-05	0.00018	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ENO2—brain cancer	2.71e-05	0.000179	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STAT3—brain cancer	2.69e-05	0.000178	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTNNB1—brain cancer	2.69e-05	0.000178	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—BSG—brain cancer	2.6e-05	0.000172	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APC—brain cancer	2.56e-05	0.000169	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CG—brain cancer	2.56e-05	0.000169	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MYC—brain cancer	2.5e-05	0.000166	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CTNNB1—brain cancer	2.48e-05	0.000164	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGFR—brain cancer	2.45e-05	0.000162	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CG—brain cancer	2.41e-05	0.00016	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STAT3—brain cancer	2.34e-05	0.000155	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—IDH1—brain cancer	2.24e-05	0.000148	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STAT3—brain cancer	2.16e-05	0.000143	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGFR—brain cancer	2.13e-05	0.000141	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—brain cancer	2.06e-05	0.000136	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MYC—brain cancer	2.01e-05	0.000133	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RELA—brain cancer	2e-05	0.000132	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ERBB2—brain cancer	1.99e-05	0.000131	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGFR—brain cancer	1.97e-05	0.00013	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—brain cancer	1.8e-05	0.000119	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ENO2—brain cancer	1.77e-05	0.000117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCND1—brain cancer	1.75e-05	0.000116	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CG—brain cancer	1.75e-05	0.000116	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CTNNB1—brain cancer	1.74e-05	0.000115	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—brain cancer	1.53e-05	0.000101	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT3—brain cancer	1.51e-05	0.0001	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MYC—brain cancer	1.41e-05	9.32e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGFR—brain cancer	1.38e-05	9.11e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CG—brain cancer	1.32e-05	8.72e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CG—brain cancer	1.24e-05	8.22e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—brain cancer	1.16e-05	7.65e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CG—brain cancer	8.11e-06	5.37e-05	CbGpPWpGaD
